Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,515.00
Bid: 3,510.00
Ask: 3,545.00
Change: -35.00 (-0.99%)
Spread: 35.00 (0.997%)
Open: 3,565.00
High: 3,565.00
Low: 3,515.00
Prev. Close: 3,550.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

13 Jul 2018 07:49

RNS Number : 5685U
Caledonia Investments PLC
13 July 2018
 

 

 

 

CALEDONIA INVESTMENTS ACQUIRES COOKE OPTICS

 

Caledonia Investments plc ("Caledonia") is pleased to announce that it has acquired a majority stake in Cooke Optics Group Ltd ("Cooke"), the UK manufacturer of premium-end cinematography lenses for the film, television and advertising industries, in a transaction which values the business at £96.5m.

 

Founded as a lens manufacturer in 1886, Cooke has been at the centre of the film making business for over a century. Headquartered in Leicester, it is led by Les Zellan (Chairman), Robert Howard (Chief Executive Officer) and Alan Merrills (Chief Operating Officer) and has some 130 full time employees.

 

Caledonia has subscribed £62.5m of equity and £30.0m of debt to acquire approximately 89% of Cooke from its current owners, Growth Capital Partners and Cooke's management team. The management team have reinvested £7.8m of their sales proceeds for the remaining equity.

 

In its most recent audited consolidated accounts, being for its financial year to 30 June 2017, Cooke reported EBITDA of £7.7m and profit before tax of £2.8m, and at that date had gross assets of £33.8m.

 

Commenting on the acquisition, Duncan Johnson, Caledonia's Head of Unquoted Investments, said:

 

"We are delighted to have become owners of such an iconic business and brand as Cooke Optics. Its profitability and high cash generation, combined with its strong competitive position in the film making industry globally, makes it ideally suited to Caledonia's unquoted portfolio. We look forward to working with Les Zellan and his team to take advantage of growth opportunities deriving from Cooke's innovation in full-frame camera lens technology, increased demand from China and the expansion of the digital streaming market globally."

 

Les Zellan, Cooke's Chairman, commented:

 

"We are delighted to be partnering with Caledonia in the next phase of Cooke's development. Caledonia's reputation as a long term, supportive investor gives us confidence that we can continue building the Cooke legacy derived from over 130 years of supporting the film industry."

 

13 July 2018

 

For further information contact:

 

 

Caledonia Investments plc

+44 20 7802 8080

Will Wyatt,

Chief Executive

 

Stephen King,

Finance Director

 

Duncan Johnson,

Head of Unquoted Investments

Media contact:

Tulchan Communications

+44 20 7353 4200

Peter Hewer

Lisa Jarrett-Kerr

This announcement contains inside information in relation to Caledonia.

 

END

 

Notes for editors:

 

Caledonia Investments plc

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of approximately £1.9bn as at 30 June 2018. The company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing annual dividend for 51 years.

 

In the unquoted arena, Caledonia seeks to invest £25m to £100m in private companies, either on a majority or minority basis, providing a meaningful presence and growth capital supporting double-digit operating margins. Its current unquoted portfolio includes Cobehold (a European unquoted investment house), Seven Investment Management (a provider of discretionary fund management, asset management and self-invest platform services), Buzz Bingo (the UK market leading retail bingo operator), Choice Care Group (a UK learning disability care homes provider) and Liberation Group (the Channel Islands' market leading pub, restaurant and drinks business).

 

For additional information on Caledonia, please visit www.caledonia.com.

 

Cooke Optics

Founded in 1886 and based in Leicester, Cooke manufacturers a wide range of lenses suitable for multiple film applications. For over a century, cinematographers have chosen Cooke lenses for the "Cooke Look", a sharp, subtle, smooth rendering that provides dimensionality and high contrast and pleases the eye.

 

For additional information on Cooke, please visit www.cookeoptics.com.

 

Transaction

Caledonia's investment in Cooke was led by Chris Hodges, Alex Mills and Theo Tizard.

 

Travers Smith (Ian Shawyer, Adam Orr) and Alvarez & Marsal (Adrian Balcombe) respectively provided legal and financial due diligence advice to Caledonia. CiL Management Consultants (Tabitha Elwes) provided commercial due diligence advice and Deloitte (Tim Haden) provided tax advice. Wyvern Partners (Mike Barnes) provided debt advice.

 

PwC (Cara Haffey) and Squire Patton Boggs (Paul Mann) respectively provided corporate finance and legal advice to the vendors.

 

 

 

Neither the contents of Caledonia's nor Cooke's websites, nor the contents of any website accessible from hyperlinks on these websites (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQGGUACMUPRUQW
Date   Source Headline
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20229:22 amRNSNet Asset Value(s)
22nd Nov 20227:00 amRNSDirectorate Change
22nd Nov 20227:00 amRNSHalf-year Report
7th Nov 202210:49 amRNSNet Asset Value(s)
7th Oct 20227:00 amRNSUnaudited net asset value and portfolio update
30th Sep 20224:21 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:51 pmRNSDirector/PDMR Shareholding
6th Sep 202210:17 amRNSNet Asset Value(s)
23rd Aug 20225:21 pmRNSDirector/PDMR Shareholding
15th Aug 20222:21 pmRNSDirector Declaration
4th Aug 202212:41 pmRNSNet Asset Value(s)
27th Jul 20224:47 pmRNSResult of AGM
19th Jul 20224:59 pmRNSDirector Declaration
7th Jul 20227:00 amRNSUnaudited net asset value and portfolio update
23rd Jun 20224:00 pmRNSAnnual Financial Report
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
16th Jun 20224:32 pmRNSDirector/PDMR Shareholding
14th Jun 20221:51 pmRNSDirector/PDMR Shareholding
8th Jun 20229:36 amRNSNet Asset Value(s)
6th Jun 20223:33 pmRNSDirector/PDMR Shareholding
31st May 20224:50 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSFinal Results
6th May 20229:02 amRNSNet Asset Value(s)
7th Apr 20227:00 amRNSUnaudited net asset value and portfolio update
4th Apr 202210:10 amRNSDirectorate Change
25th Mar 20224:47 pmRNSDirector/PDMR Shareholding
21st Mar 20223:56 pmRNSDirector/PDMR Shareholding
16th Mar 20222:05 pmRNSDirector/PDMR Shareholding
7th Mar 20227:00 amRNSDirectorate Change
7th Mar 20227:00 amRNSNet Asset Value(s)
28th Feb 20224:59 pmRNSTotal Voting Rights
4th Feb 20224:56 pmRNSTransaction in Own Shares
4th Feb 20229:52 amRNSNet Asset Value(s)
31st Jan 20225:23 pmRNSTotal Voting Rights
28th Jan 20225:25 pmRNSTransaction in Own Shares
7th Jan 202211:40 amRNSUnaudited net asset value and portfolio update
4th Jan 20227:00 amRNSTotal Voting Rights
21st Dec 20214:44 pmRNSDisposal
20th Dec 202110:00 amRNSDirector Declaration
17th Dec 20215:32 pmRNSTransaction in Own Shares
10th Dec 20215:16 pmRNSTransaction in Own Shares
7th Dec 20219:59 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.